Some of these molecules antagonise effects of insulin such as leptin or TNF-α, while others have beneficial effects such as adiponectin [18–24], with evidence that plasma CRP relates to insulin resistance independent of obesity [24, 25]. The gene discussed is CRP; the disease is obesity due to melanocortin 4 receptor deficiency.